Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ammonia levels in urine could signify chronic kidney disease
Dogs with low UACR were more likely to die of renal failure.
Dogs with lower UACR may suffer faster progression.

A new study from North Carolina State University has suggested that ammonia levels in urine could serve as a marker for chronic kidney disease in dogs.

Researchers believe that dogs with a lower urine ammonia-to-creatinine ratio (UACR) could be experiencing a faster progression of kidney disease and higher fatality rates.

For humans, chronic kidney disease is linked to an inability to excrete acids like ammonia through urine. This can lead to metabolic acidosis, which is a potentially life-threatening build-up of acid in the body.

However, researchers felt there was not enough research into the link between reduced ammonia excretion and accelerated kidney disease in dogs.

The team enrolled 50 dogs (22 female, 28 male) that were being seen for management or monitoring of International Renal Interest Society (IRIS) stage 2-4 chronic kidney disease. Each dog underwent initial blood and urine sampling to establish baselines and were seen four more times over the next 12 months.

Researchers concluded that dogs which had a UACR below 2.0 at enrolment were three times more likely to die of renal failure. They also had more rapid disease progression and experienced shorter survival times than dogs with higher UACR values.

This could mean that UACR could be used as an earlier marker of acid dysregulation than more traditional measures, including serum bicarbonate concentrations.

In the study, dogs had normal serum bicarbonate concentrations, but abnormalities in UACR levels. Altered urinary ammonia excretion could be more noticeable than changes detected in blood tests.

Autumn Harris, associate professor of nephrology-urology at NC State and first author of the study, said: “These findings indicate that UACR might serve as a clinically useful and non-invasive biomarker to identify dogs at risk of progression of their kidney disease who might benefit from early, targeted alkaline therapeutic intervention.

“Additionally, UACR could be used to help determine the prognosis for dogs with chronic kidney disease, allowing for interventions that could improve quality of life in these animals.”

The full study can be found in the Journal of Veterinary Internal Medicine.

Image © Unai Huizi/Shutterstock.com

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."